000 01209 a2200313 4500
005 20250514181913.0
264 0 _c20040511
008 200405s 0 0 eng d
022 _a1534-5823
024 7 _a10.1177/1534582303262095
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKelly, Thomas H
245 0 0 _aClinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.
_h[electronic resource]
260 _bBehavioral and cognitive neuroscience reviews
_cDec 2003
300 _a227-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aCues
650 0 4 _aHumans
650 0 4 _aNeuropharmacology
_xmethods
650 0 4 _aResearch Design
_xstandards
650 0 4 _aSubstance Abuse Detection
_xmethods
650 0 4 _aSubstance-Related Disorders
_xclassification
700 1 _aStoops, William W
700 1 _aPerry, Andrea S
700 1 _aPrendergast, Mark A
700 1 _aRush, Craig R
773 0 _tBehavioral and cognitive neuroscience reviews
_gvol. 2
_gno. 4
_gp. 227-60
856 4 0 _uhttps://doi.org/10.1177/1534582303262095
_zAvailable from publisher's website
999 _c14726326
_d14726326